Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 40 Records) |
| Query Trace: Syndrome and CYP3A5[original query] |
|---|
| Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients. Cancer chemotherapy and pharmacology 2013 Oct 72 (4): 825-35. Kim Hye Ryun, Park Hyung Soon, Kwon Woo Sun, Lee Ji Hyun, Tanigawara Yusuke, Lim Sun Min, Kim Hyo Song, Shin Sang Jun, Ahn Jung Bae, Rha Sun You |
| Both PON1 Q192R and CYP2C19*2 influence platelet response to clopidogrel and ischemic events in Chinese patients undergoing percutaneous coronary intervention. International journal of clinical and experimental medicine 2015 8 (6): 9266-74. Chen Yu, Huang Xiaohong, Tang Yong, Xie Yuquan, Zhang Yach |
| Association of CYP2C19, CYP3A5 and GPIIb/IIIa gene polymorphisms with Aspirin and Clopidogrel Resistance in a cohort of Indian patients with Coronary Artery Disease. International journal of laboratory hematology 2015 Aug . Arya V, Mahajan P, Saraf A, Mohanty A, Sawhney J P S, Bhargava |
| Clinical effects of single nucleotide polymorphisms on drug-related genes in Japanese metastatic renal cell carcinoma patients treated with sunitinib. Anti-cancer drugs 2016 Aug . Numakura Kazuyuki, Tsuchiya Norihiko, Kagaya Hideaki, Takahashi Makoto, Tsuruta Hiroshi, Inoue Takamitsu, Narita Shintaro, Huang Mingguo, Satoh Shigeru, Niioka Takenori, Miura Masatomo, Habuchi Tomono |
| Pharmacogenetic approach to losartan in Marfan patients: a starting point to improve dosing regimen? Drug metabolism and personalized therapy 2016 Jul . Falvella Felicia Stefania, Marelli Susan, Cheli Stefania, Montanelli Stefano, Viecca Federico, Salvi Lucia, Ferrara Alfio, Clementi Emilio, Trifirò Giuliana, Pini Alessand |
| Population Pharmacokinetics of Prednisolone in Relation to Clinical Outcome in Children With Nephrotic Syndrome. Therapeutic drug monitoring 2016 Apr . Teeninga Nynke, Guan Zheng, Stevens Jasper, Kist-van Holthe Joana E, Ackermans Mariëtte T, van der Heijden Albert J, van Schaik Ron H N, van Gelder Teun, Nauta Jero |
| Sufentanil and midazolam dosing and pharmacogenetic factors in pediatric analgosedation and withdrawal syndrome. Physiological research 2016 Dec 65 (Supplementum 4): S463-S472. Hronová K, Pokorná P, Posch L, Slana? |
| MDR-1 and CYP3A5 Polymorphisms in Pediatric Idiopathic Nephrotic Syndrome: Impact on Susceptibility and Response to Steroids (Preliminary Results). Clinical laboratory 2017 Jul 63 (7): 1233-1242. Moussa Amira, Mabrouk Sameh, Hamdouni Haithem, Ajmi Maroua, Tfifha Miniar, Omezzine Asma, Abroug Saoussen, Bouslama A |
| A Prediction Algorithm for Drug Response in Patients with Mesial Temporal Lobe Epilepsy Based on Clinical and Genetic Information. PloS one 2017 12 (1): e0169214. Silva-Alves Mariana S, Secolin Rodrigo, Carvalho Benilton S, Yasuda Clarissa L, Bilevicius Elizabeth, Alvim Marina K M, Santos Renato O, Maurer-Morelli Claudia V, Cendes Fernando, Lopes-Cendes Isc |
| Evaluation of Genetic Polymorphisms for Determining Steroid Response in Nephrotic Children. Annals of clinical and laboratory science 2018 Jul 48 (4): 478-483. Kara Aslihan, Gurgoze Metin Kaya, Kara Murat, Aydin Musta |
| Effect of CYP3 A4, CYP3 A5 and ABCB1 gene polymorphisms on the clinical efficacy of tacrolimus in the treatment of nephrotic syndrome. BMC pharmacology & toxicology 2018 Apr 19 (1): 14. Li Min, Xu Min, Liu Wei, Gao X |
| Pharmacogenetic landscape of Metabolic Syndrome components drug response in Tunisia and comparison with worldwide populations. PloS one 2018 13 (4): e0194842. Jmel Haifa, Romdhane Lilia, Ben Halima Yosra, Hechmi Meriem, Naouali Chokri, Dallali Hamza, Hamdi Yosr, Shan Jingxuan, Abid Abdelmajid, Jamoussi Henda, Trabelsi Sameh, Chouchane Lotfi, Luiselli Donata, Abdelhak Sonia, Kefi R |
| Genotyping and phenotyping CYP3A4\CYP3A5: no association with antiplatelet effect of clopidogrel. Molecular biology reports 2019 May . Mirzaev K B, Samsonova K I, Potapov P P, Andreev D A, Grishina E A, Ryzhikova K A, Sychev D |
| Influence of CYP3A4/5 and ABC transporter polymorphisms on lenvatinib plasma trough concentrations in Japanese patients with thyroid cancer. Scientific reports 2019 Apr 9 (1): 5404. Ozeki Tomoko, Nagahama Mitsuji, Fujita Kazuma, Suzuki Akifumi, Sugino Kiminori, Ito Koichi, Miura Masato |
| Dosage Optimization Based on Population Pharmacokinetic Analysis of Tacrolimus in Chinese Patients with Nephrotic Syndrome. Pharmaceutical research 2019 2 36 (3): 45. Lu Tong, Zhu Xu, Xu Shansen, Zhao Mingming, Huang Xueshi, Wang Zhanyou, Zhao Lim |
| Population pharmacokinetic study of tacrolimus in pediatric patients with primary nephrotic syndrome: A comparison of linear and nonlinear Michaelis-Menten pharmacokinetic model. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2019 Dec 143 105199. Huang Lingfei, Liu Yixi, Jiao Zheng, Wang Junyan, Fang Luo, Mao Jianh |
| Impact of CYP3A4/5 and ABCB1 polymorphisms on tacrolimus exposure and response in pediatric primary nephrotic syndrome. Pharmacogenomics 2019 10 20 (15): 1071-1083. Huang Lingfei, Wang Junyan, Yang Jufei, Zhang Huifen, Ni Yinghua, Zhu Zhengyi, Wang Huijuan, Gao Peng, Wu Yuanyuan, Mao Jianhua, Fang L |
| Diltiazem on tacrolimus exposure and dose sparing in Chinese pediatric primary nephrotic syndrome: impact of CYP3A4, CYP3A5, ABCB1, and SLCO1B3 polymorphisms. European journal of clinical pharmacology 2020 Aug . Wang Junyan, Huang Lingfei, Gao Peng, Hu Yan, Ni Yinghua, Zhu Zhengyi, Zhang Liwen, Yang Jufei, Zhang Huifen, Fang L |
| CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban. Pharmacogenomics and personalized medicine 2020 3 13 29-37. Sychev D A, Baturina O A, Mirzaev K B, Rytkin E, Ivashchenko D V, Andreev D A, Ryzhikova K A, Grishina E A, Bochkov P O, Shevchenko R |
| Tacrolimus treatment in childhood refractory nephrotic syndrome: A retrospective study on efficacy, therapeutic drug monitoring, and contributing factors to variable blood tacrolimus levels. International immunopharmacology 2020 2 81 106290. Guo Hong-Li, Xu Jing, Sun Jie-Yu, Li Ling, Guo Hui-Lei, Jing Xia, Xu Ze-Yue, Hu Ya-Hui, Xu Ze-Jun, Sun Fang, Ding Xuan-Sheng, Chen Feng, Zhao F |
| Multimorbidity, polypharmacy, and drug-drug-gene interactions following a non-ST elevation acute coronary syndrome: analysis of a multicentre observational study. BMC medicine 2020 11 18 (1): 367. Turner R M, de Koning E M, Fontana V, Thompson A, Pirmohamed |
| CYP3A5 genetic variants and their associations with carbamazepine and valproic acid response in Malaysian epileptic patients. International journal of clinical pharmacology and therapeutics 2020 10 59 (1): 8-16. Miyata-Nozaka Yuka, Tan Hui Jan, Wong Sau Wei, Raymond Azman Ali, Omar Haslyna, Zain Shamsul Mo |
| Kidney podocyte-associated gene polymorphisms affect tacrolimus concentration in pediatric patients with refractory nephrotic syndrome. The pharmacogenomics journal 2020 Jan . Mo Xiaolan, Li Jiali, Liu Yunfeng, Liao Xin, Tan Mei, Chen Yilu, He Fan, He Yanling, Li Yingjie, Huang M |
| Dose tailoring of tacrolimus based on a non-linear pharmacokinetic model in children with refractory nephrotic syndrome. International immunopharmacology 2021 Jul 98 107827. Li Ling, Zhu Min, Li De-Yi, Guo Hong-Li, Hu Ya-Hui, Xu Ze-Yue, Jing Xia, Chen Feng, Zhao Fei, Li Yun-Man, Xu Jing, Jiao Zhe |
| Assessment of the Link of ABCB1 and NR3C1 gene polymorphisms with the prednisolone resistance in pediatric nephrotic syndrome patients of Bangladesh: A genotype and haplotype approach. Journal of advanced research 2021 Nov 33 141-151. Parvin Most Nazma, Aziz Md Abdul, Rabbi Sikder Nahidul Islam, Al-Mamun Mir Md Abdullah, Hanif Mohammed, Islam Md Saiful, Islam Mohammad Safiq |
| Correction to: CYP3A5 and CYP3A7 genetic polymorphisms affect tacrolimus concentration in pediatric patients with nephrotic syndrome. European journal of clinical pharmacology 2021 Jan . Liu Hongxia, Xu Qinxia, Huang Wenyan, Zhao Qi, Jiang Zhihu, Kuang Xinyu, Li Zhiling, Sun Huajun, Qiu Xiaoy |
| CYP3A4*22 and CYP3A5*3 impact efficacy and safety of diazepam in patients with alcohol withdrawal syndrome. Nordic journal of psychiatry 2022 4 77 (1): 73-76. Skryabin Valentin Yurievich, Franck Johan, Lauschke Volker Martin, Zastrozhin Mikhail Sergeevich, Shipitsyn Valery Valerievich, Bryun Evgeny Alekseevich, Sychev Dmitry Alekseevi |
| Prediction of Tacrolimus Dose/Weight-Adjusted Trough Concentration in Pediatric Refractory Nephrotic Syndrome: A Machine Learning Approach. Pharmacogenomics and personalized medicine 2022 3 15 143-155. Mo Xiaolan, Chen Xiujuan, Wang Xianggui, Zhong Xiaoli, Liang Huiying, Wei Yuanyi, Deng Houliang, Hu Rong, Zhang Tao, Chen Yilu, Gao Xia, Huang Min, Li Jia |
| Tacrolimus pharmacokinetics in pediatric nephrotic syndrome: A combination of population pharmacokinetic modelling and machine learning approaches to improve individual prediction. Frontiers in pharmacology 2022 12 13 942129. Huang Qiongbo, Lin Xiaobin, Wang Yang, Chen Xiujuan, Zheng Wei, Zhong Xiaoli, Shang Dewei, Huang Min, Gao Xia, Deng Hui, Li Jiali, Zeng Fangling, Mo Xiaol |
| Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced Thyroid Cancer. International journal of molecular sciences 2023 3 24 (6): . Cantara Silvia, Dalmiglio Cristina, Marzocchi Carlotta, Sagnella Alfonso, Brilli Lucia, Trimarchi Andrea, Maino Fabio, Valerio Laura, Castagna Maria Graz |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: